Predicted Chemotherapy Benefit for Breast Cancer Patients With Germline Pathogenic Variants in Cancer Susceptibility Genes

Breast cancer patients increasingly undergo genetic testing. To examine chemotherapy indications for germline pathogenic variant (PV) carriers, we linked results of germline testing to Georgia and California Surveillance, Epidemiology, and End Results registry records, including 21-gene recurrence s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurian, Allison W, Ward, Kevin C, Abrahamse, Paul, Hamilton, Ann S, Katz, Steven J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785044/
https://www.ncbi.nlm.nih.gov/pubmed/33426465
http://dx.doi.org/10.1093/jncics/pkaa083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785044/
https://www.ncbi.nlm.nih.gov/pubmed/33426465
http://dx.doi.org/10.1093/jncics/pkaa083

Ejemplares similares